false
OasisLMS
Catalog
Concurrent Paper Session II
Concurrent Paper Session II
Concurrent Paper Session II
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
In the video, various speakers present their research on addiction medicine and the impact of the COVID-19 pandemic. Dr. Willens discusses a pilot protocol for treating methamphetamine addiction in inpatient settings using behavior-based therapies and vitamin C. Dr. Rydberg presents a study on the impact of the pandemic on overdose risk and healthcare-seeking behavior among hospitalized patients with opioid use disorder. Dr. Gopaldas shares a case series on the use of low-dose and micro-dose buprenorphine transitions followed by depot buprenorphine in hospitalized patients with medical complexity. Dr. Saval discusses a case series on low-dose or micro-dose buprenorphine transitions followed by depot buprenorphine for opioid use disorder in hospitalized patients. Overall, these presentations highlight innovative approaches and challenges in addiction medicine during the pandemic. <br /><br />In another part of the video, Jeff Russell presents findings from a retrospective chart review on patients prescribed benzodiazepines at a psychiatric clinic. The study identifies patients at risk of adverse effects of benzodiazepines and highlights the need for evidence-based prescribing interventions. The study reveals that 40% of patients in the clinic had at least one risk factor and the median duration of benzodiazepine use was over two years. Dr. Russell emphasizes the need for protocolized and evidence-based deprescribing approaches in psychiatric care. The presentation prompts discussions on benzodiazepine deprescribing strategies.<br /><br />Note: No credits were provided in either section of the video.
Keywords
addiction medicine
COVID-19 pandemic
methamphetamine addiction
behavior-based therapies
overdose risk
opioid use disorder
low-dose buprenorphine
retrospective chart review
benzodiazepines
deprescribing approaches
×
Please select your language
1
English